The largest database of trusted experimental protocols

15 protocols using guava 8ht

1

Immunophenotyping of Blood Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were blocked in PBS plus 2% FCS supplemented with 20% human serum, then labelled with antibodies (eBiosciences, Hatfield UK), for CD4+ T cells (PE-CD14 or PE-CD4), for B cells (FITC-CD3 or FITC CD19) and for monocytes (FITC-CD3 or FITC-CD14). Flow cytometry was performed using a Guava 8HT (Millipore, UK) running Guavasoft 2.5.
+ Open protocol
+ Expand
2

PD-L1 Binding Assay with Atezolizumab

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 6

Flow cytometry was performed to access binding of atezolizumab and atezolizumab bound Abraxane to the ligand, PD-L1. The PD-L1 positive melanoma cell line, C8161 was used for this experiment. AA130 was made as described above and an aliquot of the nanoparticles was spun at 6000 rpm for 10 minutes to remove any unbound atezolizumab. C8161 cells were stained with FITC labeled isotype control and anti-human PD-L1 as negative and positive controls, respectively. The C8161 cells were incubated for 30 minutes with ABX and atezolizumab alone and the AA130 nanoparticle. After the incubation the cells were labeled with FITC labeled anti-human PD-L1 for 30 minutes and washed with FACS buffer (1×PBS+0.5% BSA and 0.05% Na azide). After washing, the cells were analyzed by flow cytometer on the Guava 8HT and data analysis performed with Gauvasoft software (Millipore).

C8161 cells were pre-treated with isotype control antibody (FIG. 9A), no treatment (FIG. 9B), ABRAXANE® (FIG. 9C), atezolizumab (FIG. 9D), or AA130 (FIG. 9E), then labeled with fluorescently-labeled anti-PD-L1 antibody. The atezolizumab in the context of the 130 nm particle retains its ability to bind its ligand, PD-L1.

+ Open protocol
+ Expand
3

Analyzing PD-L1 Binding of Atezolizumab

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 3

Flow cytometry was performed to access binding of atezolizumab and atezolizumab bound Abraxane to the ligand, PD-L1. The PD-L1 positive melanoma cell line, C8161 was used for this experiment. AA130 was made as described above and an aliquot of the nanoparticles was spun at 6000 rpm for 10 minutes to remove any unbound atezolizumab. C8161 cells were stained with FITC labeled isotype control and anti-human PD-L1 as negative and positive controls, respectively. The C8161 cells were incubated for 30 minutes with ABX and atezolizumab alone and the AA130 nanoparticle. After the incubation the cells were labeled with FITC labeled anti-human PD-L1 for 30 minutes and washed with FACS buffer (1×PBS+0.5% BSA and 0.05% Na azide). After washing, the cells were analyzed by flow cytometer on the Guava 8HT and data analysis performed with Gauvasoft software (Millipore).

C8161 cells were pre-treated with isotype control antibody (FIG. 3A), no treatment (FIG. 3B), ABRAXANE® (FIG. 3C), atezolizumab (FIG. 3D), or AA130 (FIG. 3E), then labeled with fluorescently-labeled anti-PD-L1 antibody. The atezolizumab in the context of the 130 nm particle retains its ability to bind its ligand, PD-L1.

+ Open protocol
+ Expand
4

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
EDTA-contained tubes were used for drawing blood, plasma was collected and stored after centrifugation. Fresh blood samples were surface stained with antibodies (Abs) at room temperature for 10 min, red cells were lysed, and the cells were washed and analyzed by flow cytometry. The fluorochrome-labeled monoclonal Abs used for flow cytometry included the following: Abs against CD4-Parcific Blue, CD19-FITC, CD3-Percp, CD8-APC, PD1-PE, CXCR5-APCcy7, CD45RO-PEcy7, and isotype control Abs (BD Pharmingen, San Jose, CA; and Biolegend, San Diego, CA). A Guava 8HT flow cytometer (Millipore, Billerica, MA) was used to harvest and analyze cells.
+ Open protocol
+ Expand
5

Bone Marrow and Blood Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow was harvested from the tibias, femurs, hip bones, radius, and ulnas. Samples were hemolyzed and cells were counted on a Millipore Guava 8HT. Cells were stained in FACS buffer (5% FBS, 4mM EDTA) with 5% anti-FC (24G2 hybridoma lysate) and antibodies (Table S1). For analysis of peripheral blood, 20uL of peripheral blood was harvested from the tail into 50uL heparin, hemolyzed, and stained for the indicated surface markers (Table S1).
+ Open protocol
+ Expand
6

Dose-dependent Cytotoxicity of ABX and AA130 in C8161 Melanoma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 4

C8161 melanoma cells were exposed to ABX and AA130 at paclitaxel concentrations from 0 to 200 μg/mL overnight to determine cell toxicity. The cells were also incubated with EdU, a thymidine analog. The next day the cells were harvested, fixed with 2% paraformaldehyde and permeabolized with 1% saponin. After permeabolization the cells were incubated for 30 minutes with a FITC labeled anti-EdU antibody to determine the percentage of cells proliferating. After washing, the cells were analyzed by flow cytometer on the Guava 8HT and data analysis performed with Gauvasoft software (Millipore). The proliferation index was calculated by normalization to an untreated positive control.

FIG. 4 shows the dose-dependent toxicity of ABX (solid line) and AA130 (broken line) on C8161 cells. The AA130 nanoparticle complex has cellular toxicity similar to ABX alone.

+ Open protocol
+ Expand
7

Multicolor Flow Cytometry for Cell Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The fluorochrome-labeled monoclonal antibodies used in this study included: antibodies against CD14-percp (BD), CD16-FITC (BD Pharmingen), IL-6-phycoerytherin (PE, BD Pharmingen), CD80-allophycocyanin (APC, BD Pharmingen), CD86-PE, and isotype control antibodes (BD Pharmingen). Cells were identified by their forward and side scatter characteristics and were analyzed by flow cytometry on a Guava 8HT flow cytometer (Millipore, Billerica, MA).
+ Open protocol
+ Expand
8

Flow Cytometry Analysis of Adipose-Derived Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The stromal vascular fraction samples were analyzed for the presence of adipose-derived mesenchymal stem cells using flow cytometry (Guava 8HT; Millipore, Billerica, Mass.). To obtain enough cells for flow cytometry, cultured stromal vascular fractions were used at passage 0 after cells reached 75 percent confluence. Single-cell suspensions from passage 0 cells were stained with mouse anti-human CD14–fluorescein isothiocyanate (1 μg/ml), CD19–fluorescein isothiocyanate (1 μg/ml), CD90-fluorescein isothiocyanate (1 μg/ml), CD105–fluorescein isothiocyanate (1 μg/ml), CD73-phycoerythrin (1 μg/ml), CD45-phycoerythrin (1 μg/ml), CD34-phycoerythrin (1 μg/ml), and CD13-phycoerythrin (1 μg/ml) using standard protocols.45 (link) Mouse fluorescein isothiocyanate– or phycoerythrin-conjugated mouse immunoglobulin G1 (1 μg/ml) was used as an isotype control. Fluorescein isothiocyanate–conjugated antibodies were purchased from Serotec (Raleigh, N.C.) and phycoerythrin-conjugated antibodies were purchased from BD Biosciences (San Jose, Calif.).
+ Open protocol
+ Expand
9

Multiparametric Flow Cytometry of PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Freshly thawed or CMV-stimulated PBMC were washed in staining medium and incubated for 30 min at 4°C with surface markers. For intracellular Granzyme B, TGFβ, IL-35 and IL-10 staining, PBMC were then permeabilized and fixed (Cytofix/Cytoperm; BD Biosciences) for 20 min at 4°C, washed and incubated with the appropriate mAbs. For intranuclear FoxP3, cells were permeabilized and fixed with IC Fixation and permeabilization buffer (eBiosciences) for 1 hour at 4°C, washed and incubated with the mAb. At the completion of the staining procedure, cells were fixed in 2% paraformaldehyde (Electron Microscopy Sciences) in PBS and data were acquired with Guava 8HT (Millipore) or Gallios (Beckman Coulter). Results were analyzed with FlowJo (Treestar) or Kaluza (Beckman Coulter).
+ Open protocol
+ Expand
10

Dose-Dependent Toxicity of ABX and AA130 on C8161 Melanoma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 7

C8161 melanoma cells were exposed to ABX and AA130 at paclitaxel concentrations from 0 to 200 μg/mL overnight to determine cell toxicity. The cells were also incubated with EdU, a thymidine analog. The next day the cells were harvested, fixed with 2% paraformaldehyde and permeabolized with 1% saponin. After permeabolization the cells were incubated for 30 minutes with a FITC labeled anti-EdU antibody to determine the percentage of cells proliferating. After washing, the cells were analyzed by flow cytometer on the Guava 8HT and data analysis performed with Gauvasoft software (Millipore). The proliferation index was calculated by normalization to an untreated positive control.

FIG. 10 shows the dose-dependent toxicity of ABX (solid line) and AA130 (broken line) on C8161 cells. The AA130 has cellular toxicity similar to ABX alone.

+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!